Spinal cord injury and Alzheimer's risk among topics at American Chemical Society meeting

ORLANDO, Fla. More than 6,500 cutting-edge research findings will be presented at the 223rd national meeting of the American Chemical Society, April 7-11, in Orlando. Nearly 11,000 scientists are expected to attend the meeting, which will be held at the Orange County Convention Center.

Highlights include:

  • Regeneration of damaged nerves
  • Predicting whos at risk for Alzheimers disease
  • Government and industry roles in responding to terrorism
  • Roles of science and technology in our energy future
  • Nurturing partnerships with the Cuban scientific community
  • Targeting diabetic nerve and eye damage
  • Women in the Manhattan Project
  • Fatty acids vs. postpartum depression
  • New approaches to treatment of osteoporosis

Note: Reporters with access to embargoed stories on EurekAlert! may see a more detailed embargoed overview of the meeting by clicking here.

News releases and advisories will be posted on the World Wide Web, on an embargoed basis, at www.eurekalert.org under the "ACS 223rd national meeting" button. They will also be posted at www.chemistry.org when the embargoes are lifted.

The meeting is open to accredited news media. The pressroom will be located in Room 309A, on the third level of the Convention Center. It will open for on-site registration from noon to 6 p.m., Saturday, April 6, and it will be open Sunday through Wednesday from 8 a.m. until 6 p.m., and on Thursday from 8 a.m. to noon, Eastern Time.

News media must register at the pressroom to receive badges for admittance to events. Press kits will include a complete set of meeting abstracts, news releases on selected research papers, and a schedule of news briefings. For more


Page: 1 2

Related biology news :

1. Salk news: Spinal cord injury
2. Spinal cord injury and Alzheimers risk among topics at American Chemical Society meeting
3. High-Pressure Chambers Could Prevent Paralysis After Spinal Cord Injury
4. Spinal Cord Injury Treatment May Improve With New Findings On Nervous System Damage
5. Existing drug may prevent brain injury and seizures in newborns
6. Study of ProCord for neurologically complete spinal cord injury
7. Loyola decides to test new blood substitute in trauma patients at the scene of injury
8. Combination therapy dramatically improves function after spinal cord injury in rats
9. Pre-term labor drug sensitizes brain to pesticide injury
10. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
11. Kidney injurys harmful effects on bones blocked in mice

Post Your Comments:

(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... Commercial launch ... on pharma’s ability to discover a COVID cure or vaccine, the global economic downturn ... and price pressure is not going away and capturing full value from every product ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... 22, 2020 , ... Join experts from Reed Tech , Gary Saner, ... a one hour live webinar on Thursday, August 13, 2020 at 11am ... and medical devices. Specifically, for medical devices, the NMPA has departments dealing with medical ...
(Date:7/18/2020)... ... 16, 2020 , ... “We are thrilled to deliver this new technology to ... of its kind on the market and we were pleased that the IFT jury ... traditional cultured ingredients, creating a natural way to extend the shelf life and improve ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
Breaking Biology Technology:
Cached News: